The role of somatostatin receptor scintigraphy in the management of pituitary tumours

Nucl Med Commun. 2002 Feb;23(2):117-20. doi: 10.1097/00006231-200202000-00002.

Abstract

The detection of functioning neuroendocrine tissue bearing somatostatin receptors has been facilitated to a large extent by the availability of radiolabelled octreotide scanning with 111In octreotide. This review discusses the possible role for somatostatin receptor scintigraphy (SRS) in the evaluation of pituitary adenomas.

Publication types

  • Review

MeSH terms

  • Adenoma / diagnostic imaging*
  • Adenoma / metabolism
  • Adrenocorticotropic Hormone / metabolism
  • Growth Hormone / blood
  • Growth Hormone / metabolism
  • Growth Hormone-Releasing Hormone / metabolism
  • Hormones, Ectopic
  • Humans
  • Indium Radioisotopes
  • Octreotide / analogs & derivatives
  • Pituitary Neoplasms / diagnostic imaging*
  • Pituitary Neoplasms / metabolism*
  • Predictive Value of Tests
  • Radionuclide Imaging
  • Receptors, Somatotropin / analysis
  • Receptors, Somatotropin / metabolism*

Substances

  • Hormones, Ectopic
  • Indium Radioisotopes
  • Receptors, Somatotropin
  • Adrenocorticotropic Hormone
  • Growth Hormone
  • Growth Hormone-Releasing Hormone
  • Octreotide